Author:
Ordaz-Vázquez Anabel,Torres-González Pedro,Ferreyra-Reyes Leticia,Canizales-Quintero Sergio,Delgado-Sánchez Guadalupe,García-García Lourdes,Ponce-De-León Alfredo,Sifuentes-Osornio José,Bobadilla-Del-Valle Miriam
Abstract
Abstract
Background
Mycobacterium tuberculosis genotyping has been crucial to determining the distribution and impact of different families on disease clinical presentation. The aim of the study was to evaluate the associations among sociodemographic and clinical characteristics and M. tuberculosis lineages from patients with pulmonary tuberculosis in Orizaba, Veracruz, Mexico.
Methods
We analyzed data from 755 patients whose isolates were typified by 24-loci mycobacterial interspersed repetitive unit–variable number of tandem repeats (MIRU–VNTR). The associations among patient characteristics and sublineages found were evaluated using logistic regression analysis.
Results
Among M. tuberculosis isolates, 730/755 (96.6%) were assigned to eight sublineages of lineage 4 (Euro-American). Alcohol consumption (adjusted odds ratio [aOR] 1.528, 95% confidence interval (CI) 1.041–2.243; p = 0.030), diabetes mellitus type 2 (aOR 1.625, 95% CI 1.130–2.337; p = 0.009), sputum smear positivity grade (3+) (aOR 2.198, 95% CI 1.524–3.168; p < 0.001) and LAM sublineage isolates (aOR 1.023, 95% CI 1.023–2.333; p = 0.039) were associated with the presence of cavitations. Resistance to at least one drug (aOR 25.763, 95% CI 7.096–93.543; p < 0.001) and having isolates other than Haarlem and LAM sublineages (aOR 6.740, 95% CI 1.704–26.661; p = 0.007) were associated with treatment failure. In a second model, multidrug resistance was associated with treatment failure (aOR 31.497, 95% CI 5.119–193.815; p < 0.001). Having more than 6 years of formal education was not associated with treatment failure.
Conclusions
Knowing M. tuberculosis genetic diversity plays an essential role in disease development and outcomes, and could have important implications for guiding treatment and improving tuberculosis control.
Funder
Consejo Nacional de Ciencia y Tecnología
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. World Health Organization. Global tuberculosis report 2021. https://www.who.int/publications/i/item/9789240037021.
2. CENAPRECE, 2022. Programas Preventivos. Direccion de Micobacteriosis. Casos Nuevos de Tuberculosis Pulmonar. Estados Unidos Mexicanos 1990–2016. http://www.cenaprece.salud.gob.mx/programas/interior/micobacteriosis/tuberculosis/cifras_oficiales.html.
3. Blanco-Guillot F, Castaheda-Cediel ML, Cruz-Hervert P, Ferreyra-Reyes L, Delgado-Sanchez G, Ferreira-Guerrero E, et al. Genotyping and spatial analysis of pulmonary tuberculosis and diabetes cases in the state of Veracruz, Mexico. PLoS ONE. 2018;13(3): e0193911.
4. Coll F, McNerney R, Guerra-Assunção JA, Glynn JR, Perdigão J, Viveiros M, et al. A robust SNP barcode for typing Mycobacterium tuberculosis complex strains. Nat Commun. 2014;5:4812.
5. Coscolla M, Gagneux S, Menardo F, Loiseau C, Ruiz-Rodriguez P, Brites D. Phylogenomics of Mycobacterium africanum reveals a new lineage and a complex evolutionary history. Microb Genom. 2021;7(2): 000477.